Crescendo Bioscience, Inc.
Part of Myriad Genetics Inc.
- UEI
- KJ1FJFKF1PM9
- CAGE
- 488Y3
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- Corporate family
-
-
Myriad Genetics Inc.
Parent
DGD1LL6KYLC8
- Crescendo Bioscience, Inc. KJ1FJFKF1PM9
-
Myriad Genetics Inc.
Parent
DGD1LL6KYLC8
- SAM.gov registration date
- Website
- myriad.com
- Founded
- 1991
- Employees
- 1K-5K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Rheumatoid arthritis disease activity testing | Veterans Integrated Service Network 2 | $2,299 | |
| Rheumatoid arthritis disease activity testing | Veterans Integrated Service Network 2 | $4,023 | |
| Rheumatoid arthritis disease activity testing | Veterans Integrated Service Network 2 | $8,622 | |
| Rheumatoid arthritis disease activity testing | Veterans Integrated Service Network 2 | $16,093 | |
| Rheumatoid arthritis disease activity testing | Veterans Integrated Service Network 2 | $29,888 |
Quick answers
What is Crescendo Bioscience, Inc.'s UEI?
Crescendo Bioscience, Inc.'s Unique Entity ID (UEI) in SAM.gov is KJ1FJFKF1PM9.
What is Crescendo Bioscience, Inc.'s CAGE code?
Crescendo Bioscience, Inc.'s CAGE code is 488Y3.
What is Crescendo Bioscience, Inc.'s primary NAICS code?
Crescendo Bioscience, Inc.'s primary NAICS code is 621511 (Medical Laboratories).
Is Crescendo Bioscience, Inc. registered in SAM.gov?
Crescendo Bioscience, Inc.'s SAM.gov registration expired on December 14, 2021.
Who is Crescendo Bioscience, Inc.'s parent company?
Crescendo Bioscience, Inc. is part of Myriad Genetics Inc.
What is Crescendo Bioscience, Inc.'s most recent federal award?
Crescendo Bioscience, Inc.'s most recent federal contract award is Rheumatoid arthritis disease activity testing (36C24221F0105), from Veterans Integrated Service Network 2, on December 19, 2020.
On GovTribe
See Crescendo Bioscience, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors